Owens & Minor Q2 2025 slides: Company maintains positive outlook despite challenges

Owens & Minor's Q2 2025 earnings presentation reaffirmed its full-year 2025 financial guidance, projecting revenue of $2.76B-$2.82B, adjusted EBITDA of $376M-$382M, and adjusted EPS of $1.02-$1.07. The company anticipates approximately 70% of its earnings and cash flow to be generated in the second half of the year, highlighting a back-loaded performance expectation. While OMI plans substantial capital expenditures of $205M-$215M gross for growth initiatives, including the RoTEK acquisition, significant projected interest expenses of $97M-$100M and ongoing tariff pressures of $100M-$150M exposure present notable headwinds despite a recent stock rebound that leaves shares well below their 52-week high.

Analysis

Owens & Minor (OMI) reaffirmed its full-year 2025 financial guidance, projecting revenue between $2.76 billion and $2.82 billion and adjusted EPS of $1.02-$1.07, indicating management's confidence in its strategic direction. This outlook builds on a first quarter that saw a 5% increase in adjusted EBITDA and 20% growth in adjusted net income. However, the guidance carries significant execution risk, as approximately 70% of the company's earnings and cash flow are expected in the second half of the year. Key financial headwinds include a substantial projected interest expense of $97-$100 million and a previously identified tariff exposure of $100-$150 million, which will pressure bottom-line results. The company's strategy involves heavy investment in growth, with gross capital expenditures planned at $205-$215 million, partly to support the integration of the RoTEK acquisition. While the stock's recent 12.36% price increase suggests some positive sentiment, it remains considerably below its 52-week high, reflecting investor caution regarding the back-loaded nature of the guidance and the aforementioned financial pressures.

Key Decisions for Investors

• Investors should closely monitor the company's performance in the upcoming quarters, as the back-loaded guidance, with 70% of earnings expected in H2 2025, creates significant execution risk.
• It is crucial to factor the high projected interest expense of $97-$100 million and the unresolved $100-$150 million tariff exposure into valuation models, as these will materially impact net profitability.
• Consider the stock's current valuation, well below its 52-week high, as a potential risk-reward scenario contingent on management's ability to successfully navigate headwinds and deliver on its ambitious second-half targets.
• Evaluate the long-term growth potential from the significant capital expenditures and the RoTEK acquisition against the near-term pressures on cash flow and profitability.